PICF7 is a bacterial endophyte validated as an effective biological control agent against Fusarium wilt (TR4 and STR4) in banana. It colonizes banana roots, triggers plant defense responses, and shows minimal disruption to the native root microbiota, offering a sustainable alternative to conventional fungicides for protecting Cavendish and other banana cultivars.
Fusarium wilt of banana, caused by Fusarium oxysporum f. sp. cubense (including tropical race 4 and subtropical race 4), is one of the most devastating diseases threatening global banana production, particularly the Cavendish variety. This offering presents Streptomyces strain PICF7, a bacterial endophyte that has been validated under controlled conditions as an effective biological control agent (BCA) against both TR4 and STR4 strains of the pathogen. PICF7 outperformed indigenous rhizobacteria isolated from banana roots in the Canary Islands, demonstrating superior protective capacity. Importantly, introduction of PICF7 into the banana holobiont did not significantly alter the composition or structure of the indigenous root microbiota, conferring an ecological advantage over competing biocontrol strains. This solution addresses the urgent need for sustainable, environmentally responsible disease management tools in banana cultivation.
Key features and capabilities:
Future development needs:
PICF7 has completed validation under controlled laboratory and greenhouse conditions, confirming its efficacy as a biological control agent against Fusarium wilt and its compatibility with the banana root microbiome. The strain is now ready to advance toward field deployment. Next steps include formulation development, large-scale production, multi-site field trials, and comprehensive environmental risk assessment to support regulatory approval and commercial adoption. The technology is at an early-to-mid stage of development, transitioning from proof-of-concept toward pilot-scale validation.
Consejo Superior de Investigaciones Científicas (CSIC) is Spain’s national public research organization and the country’s largest R&D institution, with a nationwide network of institutes across major innovation hubs. Many labs are co‑located with universities, hospitals, and science parks, giving partners plug‑and‑play access to advanced facilities, pilot‑scale capabilities, and testing services. Industry collaborates through contract research, sponsored development, and shared core facilities, with pathways into multi‑site European consortia. Research is supported by competitive European programs and Spain’s national funding agencies. A dedicated technology transfer office manages IP, licensing, and spin‑off formation to accelerate commercialization.